Standard Operating Procedure on Targeted Spontaneous Reporting for Dolutegravir-based and Pre-exposure Prophylaxis Regimens

Published : January 16, 2024

The purpose of this standard operating procedure is to outline a step-by-step approach in implementing targeted spontaneous reporting for monitoring the safety of dolutegravir (DTG)-based regimens and pre-exposure prophylaxis (PrEP) regimens.

Resources Focus Area: HIV/AIDS | Pharmacovigilance | Regulatory Systems
Geography: Philippines